publication date: Dec. 18, 2010

In this issue: 

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

NCI Barred PI Wolmark And Its Own Prevention Staff From Ad Hod Meeting.

NCI Director To Decide Fate Of P-4 After NCAB Meeting In June.

Paul Goss, Patricia Ganz Discuss Breast Cancer Prevention Trials.

Aranesp Study Finds No Difference In Survival Or Progression In Small-Cell Lung Cancer.

Download (PDF 702KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.